Monthly Archives: March 2016

http://www.lslog.com/biosimilars-represent-a-56-110-billion-savings-potential-in-2016-2020-says-ims-institute/Biosimilars represent a $56-110-billion savings potential in 2016-2020, says IMS Institute

Biosimilars represent a $56-110-billion savings potential in 2016-2020, says IMS Institute

The IMS Institute for Healthcare Informatics has looked at how the biosimilars market is evolving, finding that there will be substantial savings to payers in the 2016-2020 time frame. However, […]

http://www.lslog.com/imprimis-pharmaceuticals-pushes-the-definition-of-pharmaceutical-manufacturing/Imprimis Pharmaceuticals pushes the definition of pharmaceutical manufacturing

Imprimis Pharmaceuticals pushes the definition of pharmaceutical manufacturing

Imprimis Pharmaceuticals (San Diego) provided its FY2015 financial data on March 23, announcing a 500% increase in revenue—but, at $9.7 million for the full year, its total revenue is barely […]